FT
Faeth Therapeutics, Inc.
SEC filingBiotechnology · Austin, TX
Amount raised$24.4Msold at filing
Total offering$25M$566K still open
Investors in the raise35count reported to the SEC
FiledJan 27, 2026first sale Aug 1, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jayson DallasDirector
Anand ParikhExecutive Officer, Director, Promoter
Alex MorganDirector
Robert GouldDirector
Stephen HahnDirector
Oliver MaddocksExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.